In the in vivo models, GNC–siRNA complex enhanced the blood circulation and the accumulation of NGF siRNA to tumour sites (Fig. 5), induced significant NGF silencing (Figs 6, 7, 8). The gene discussed is NGF; the disease is gangliocytoma.